Bio-Rad Laboratories, Inc.
BIOB
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.54B | 1.42B | 1.37B | 1.66B | 1.66B |
| Total Receivables | 472.50M | 474.20M | 478.00M | 438.40M | 465.60M |
| Inventory | 740.70M | 783.20M | 798.80M | 790.10M | 760.00M |
| Prepaid Expenses | 136.50M | 152.00M | 149.60M | 125.40M | 122.60M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.80M | 14.00M | 10.90M | 22.30M | 17.60M |
| Total Current Assets | 2.91B | 2.84B | 2.81B | 3.04B | 3.03B |
|
|
|||||
| Total Current Assets | 2.91B | 2.84B | 2.81B | 3.04B | 3.03B |
| Net Property, Plant & Equipment | 709.90M | 720.50M | 740.10M | 681.70M | 688.60M |
| Long-term Investments | 579.80M | 578.70M | 581.60M | 414.60M | 410.50M |
| Goodwill | 579.80M | 578.70M | 581.60M | 414.60M | 410.50M |
| Total Other Intangibles | 174.30M | 388.40M | 396.90M | 296.10M | 293.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 103.80M | 110.20M | 109.20M | 105.00M | 103.50M |
| Total Assets | 10.58B | 9.70B | 10.21B | 9.53B | 9.36B |
|
|
|||||
| Total Accounts Payable | 129.00M | 128.80M | 139.30M | 137.90M | 122.30M |
| Total Accrued Expenses | 172.30M | 182.80M | 157.80M | 157.40M | 124.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.40M | 38.10M | 40.60M | 42.50M | 42.90M |
| Total Finance Division Other Current Liabilities | 178.30M | 172.60M | 211.20M | 168.80M | 178.40M |
| Total Other Current Liabilities | 178.30M | 172.60M | 211.20M | 168.80M | 178.40M |
| Total Current Liabilities | 517.00M | 522.30M | 548.90M | 506.60M | 467.80M |
|
|
|||||
| Total Current Liabilities | 517.00M | 522.30M | 548.90M | 506.60M | 467.80M |
| Long-Term Debt | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 154.40M | 164.60M | 173.70M | 135.30M | 140.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.26B | 1.08B | 1.17B | 1.01B | 995.20M |
| Total Liabilities | 3.12B | 2.96B | 3.09B | 2.85B | 2.79B |
|
|
|||||
| Common Stock & APIC | 476.00M | 461.90M | 484.60M | 475.70M | 463.20M |
| Retained Earnings | 8.18B | 7.46B | 7.80B | 7.48B | 7.42B |
| Treasury Stock & Other | -1.20B | -1.18B | -1.15B | -1.28B | -1.31B |
| Total Common Equity | 7.45B | 6.74B | 7.13B | 6.68B | 6.57B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.45B | 6.74B | 7.13B | 6.68B | 6.57B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.45B | 6.74B | 7.13B | 6.68B | 6.57B |
|
|
|||||